Medscape Medical NewsAll articles

Uscan

EchoNous, Inc. • Radiology • 07/10/2018

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The Uscan is a portable diagnostic ultrasound system designed to provide non-invasive B-mode imaging for a range of clinical applications, including abdominal, musculoskeletal, pediatric, small organ, and peripheral vessel assessments, along with automated bladder volume calculation. It functions by utilizing interchangeable ultrasound probes connected to an off-the-shelf tablet running dedicated software, employing pulsed echo principles to generate real-time anatomical visualizations for diagnostic support.

Summary

The Uscan is a hand-held, portable diagnostic ultrasound system designed for non-invasive imaging of the human body. It acquires ultrasound echo data for B-Mode display on an off-the-shelf tablet, supporting applications such as abdominal, musculoskeletal, pediatric, and small organ (prostate) imaging, alongside automated bladder volume determination; this version notably expands its utility to peripheral vessel imaging, including guidance for needle and catheter placement. The system's methodology is rooted in fundamental pulsed echo ultrasound technology, utilizing interchangeable transducer probes—specifically a Sector Probe (B3-5) for general applications and a Linear Probe (L14-6) for peripheral vascular tasks, operating within a 3.0 – 14.0 MHz frequency range; the Uscan software, running as an app on a standard Android tablet, controls the device, and while primarily a 2D/B-mode imaging system, non-clinical bench testing has confirmed its imaging performance and measurement accuracy, emphasizing its design for portability and ease of use in diverse clinical environments.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

UltrasoundDiagnostic ImagingHand-heldBladder VolumeB-ModeAbdominal ImagingMusculoskeletal ImagingPediatric ImagingPeripheral Vessel ImagingTransducer

Device Metadata

Submission Number
K181574
Company
EchoNous, Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. What is the validated accuracy and inter-observer variability of the Uscan's automated bladder volume measurement across diverse patient demographics (e.g., varying BMI, bladder fullness, prior pelvic surgery)?; How does the image quality (e.g., resolution, penetration, contrast) of the Uscan's Linear Probe (L14-6) for peripheral vessel imaging compare to established hand-held ultrasound systems, particularly in visualizing smaller vessels or deeper structures?; What specific training protocols or proficiency benchmarks are recommended for clinicians to effectively utilize the Uscan for its full range of indications, especially for the newly added peripheral vessel and needle guidance applications?; Are there any performance limitations or considerations when using different 'off-the-shelf' Android tablets with the Uscan software, particularly concerning processing speed, display calibration, or battery life during prolonged use?; Could the Uscan platform be expanded to include other imaging modes (e.g., M-mode, basic Doppler) through software updates, or is it hardware-limited to B-mode imaging?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score30/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials
- Not detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server, platform)
✓ Detected
HBOMHardware Bill of Materials(hardware)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SaaSBOM, HBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Uscan - EchoNous, Inc. | ESL FDA AI Device Intelligence